|
||||||||
Company Profile | ||||||||
Chairman | CEO | Spokesperson | Tel | Address | Date of Listing (Regular) | |||
---|---|---|---|---|---|---|---|---|
Lu,Alan | Wang,Wen-Hsi | Wang,Wen-Hsi | 03-6683088 | 1F., No. 188, Sec. 1, Shengyi Rd.,Hsinchu Science Park,Zhubei City,Hsinchu County,Taiwan,R.O.C | 2019/06/05 | |||
Industry | Main Business | |||||||
Biotechnology and Medical Care | Taiwan Biomaterial Co., Ltd. (TWBM) is a spinoff startup from the Industrial Technology and Research Institute (ITRI), the largest applied technology R&D institute in Taiwan. The core team has dedicated themselves in the field of implantable medical devices for more than 10 years. The key competency of the company is founded on the basis of the team’s long-term cooperation with physicians and surgeons to jointly identify clinically unmet needs. Based on the established needs, TWBM then integrate medical key opinion leaders, research team and industry manufacturer to proceed to develop a product through processes such as proof of concept, translational research, patent portfolio, GMP pilot manufacture, clinical trials as well as other related regulatory affairs, such as CE and FDA submission and clearances. |
Market Information ( 2024/05/10 ) | |||||||||||
Shr. Vol. | Highest | Lowest | Closed | Change | Transaction | TurnOver(%) | long margin balance (1,000shr.) |
Short margin balance (1,000shr.) |
|||
---|---|---|---|---|---|---|---|---|---|---|---|
21.171 | 30.50 | 29.90 | 30.30 | 0.20 | 60 | .00 | 205 | 0 | |||
Trading method | Fun purchase price or securities pneeded on T day |
Announcement of Irregularity (2024/05/10) |
TPEx measures adopted (2024/05/10) |
With warrants | Can be shorted or margined? | Detail | |||||
Normal | N | N | N | N | Y | Today | History |
Financial Reports | |||||
---|---|---|---|---|---|
Cash Flows | Items | ||||
Amount (NT$ thousand) |
|||||
Cash flows from operating activities | |||||
Cash flows from investing activities | |||||
Cash flows from financing activities | |||||
Balance Sheets |
Current assets | ||||
Non-current assets | |||||
Total assets | |||||
Current liabilities | |||||
Non-current liabilities | |||||
Total liabilities | |||||
Share capital | |||||
Capital surplus | |||||
Retained earnings | |||||
Other equity interest | |||||
Treasury shares | |||||
Total equity attributable to owners of parent | |||||
Non-controlling interests | |||||
Total equity | |||||
Book Value per share(NT$) | |||||
Comprehensive Income | Operating revenue | ||||
Operating costs | |||||
Gross profit from operations | |||||
Operating expenses | |||||
Net other income (expenses) | |||||
Net operating income | |||||
Non-operating income and expenses | |||||
Profit before tax | |||||
Tax expense | |||||
Profit from continuing operations | |||||
Profit from discontinued operations | |||||
Profit | |||||
Other comprehensive income | |||||
Comprehensive income | |||||
Basic earnings per share |
Auditor's report on latest financial statements: auditor's report: |
More detail:MOPS。 |
Foreign issuers’ information is disclosed in consolidated statements. |